I agree that this site is using cookies. You can find further informations here.
X
Moyo, Tamara
50  results:
Search for persons X
?
1

Prognostic significance of myeloid-derived suppressor cells..:

Foureau, David M. ; Guo, Fei ; Steuerwald, Nury M....
Experimental Hematology.  129 (2024)  - p. 104125 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Outcomes of marginal zone lymphoma treated with ibrutinib i..:

Epperla, Narendranath ; Zhao, Qiuhong ; Moyo, Tamara...
Blood Advances.  8 (2024)  3 - p. 549-552 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Impact of race and social determinants of health on outcome..:

Karmali, Reem ; Machhi, Rushad ; Epperla, Narendranath...
Blood Advances.  8 (2024)  10 - p. 2592-2599 , 2024
Link: https://doi.org/10.1182/..
 
?
4

Multicenter, Real-World Study in Patients with R/R Large B-..:

Palomba, M. Lia ; Crombie, Jennifer L. ; Nastoupil, Loretta J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S40-S41 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Subsequent malignant neoplasms in patients previously treat..:

Melody, Megan ; Epperla, Narendranath ; Shouse, Geoffrey...
Blood Advances.  8 (2024)  10 - p. 2327-2331 , 2024
Link: https://doi.org/10.1182/..
 
?
6

Revisiting the role of autologous stem cell transplant in r..:

Moyo, Tamara K.
Transplantation and Cellular Therapy.  29 (2023)  8 - p. 480-481 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Postibrutinib relapse outcomes for patients with marginal z..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
Blood Advances.  7 (2023)  1 - p. 88-91 , 2023
Link: https://doi.org/10.1182/..
 
?
8

Peri–CAR-T practice patterns and survival predictors for al..:

Zurko, Joanna ; Nizamuddin, Imran ; Epperla, Narendranath...
Blood Advances.  7 (2023)  12 - p. 2657-2669 , 2023
Link: https://doi.org/10.1182/..
 
?
9

Corrigendum to "Acceleration of spleen segmentation with en..:

Moon, Hyeonsoo ; Huo, Yuankai ; Abramson, Richard G....
Computers in Biology and Medicine.  140 (2022)  - p. 103684 , 2022
Link: https://doi.org/10.1016/..
 
?
10

The ABNL-MARRO 001 study: a phase 1–2 study of randomly all..:

Moyo, Tamara K. ; Mendler, Jason H. ; Itzykson, Raphael...
BMC Cancer.  22 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
11

Predictive factors and outcomes for ibrutinib in relapsed/r..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
Journal of Hematology & Oncology.  15 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
12

A Review of Chimeric Antigen Receptor T-Cell Therapy for My..:

Atrash, Shebli ; Moyo, Tamara K
OncoTargets and Therapy.  14 (2021)  - p. 2185-2201 , 2021
Link: https://doi.org/10.2147/..
 
?
13

Rituximab, lenalidomide, and ibrutinib in relapsed/refracto..:

Moore, Donald C. ; Soni, Amy C. ; Hu, Bei...
British Journal of Haematology.  196 (2021)  4 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
14

Equal access to care and nurse navigation leads to equitabl..:

Hu, Bei ; Boselli, Danielle ; Pye, Lisa M....
Cancer.  127 (2021)  21 - p. 3991-3997 , 2021
Link: https://doi.org/10.1002/..
 
?
15

The delta isoform of phosphatidylinositol-3-kinase predomin..:

Villaume, Matthew T. ; Arrate, M. Pia ; Ramsey, Haley E....
Experimental Hematology.  97 (2021)  - p. 57-65.e5 , 2021
Link: https://doi.org/10.1016/..
 
1-15